Haofeng Medical was invited to attend the 3rd Yangtze River Delta Medical Device Industry Development Promotion Association

More

The originator of domestic cardiovascular intervention submitted the listing application, and the overseas revenue of Yeju Medical accounted for more than 80%

Yeju Medical Group Holdings, a leading vascular intervention company, filed an application with the Stock Exchange of Hong Kong on Nov 23 to list on the main board.

More

Medtec China 2022 and International Medical Device Design and Manufacturing Technology Exhibition has been postponed

In order to ensure the maximum benefit of exhibitors and visitors, in combination with the recent epidemic prevention situation, after repeated consideration, multi-party hearing and communication, the organizer has decided to host Informa Markets. The Medtec China 2022 and 17th International Medical Device Design and Manufacturing Technology Exhibition, originally scheduled for December 7-9, 2022, has been postponed. The specific time and information will be notified later.

More

The CroiValve Duo Transcatheter Tricuspid valve Repair system was successfully implanted in humans for the first time

CroiValve has announced that its Duo tricuspid valve repair technology has been successfully implanted in humans for the first time to treat tricuspid regurgitation (TR) as part of its TANDEM I study in Poland.

More

Cleveland Clinic Unveils Top 10 Healthcare Innovations for 2022 (Part 1)

The Cleveland Clinic, a leading global healthcare organization, has announced its top 10 healthcare innovations for 2022. The breakthrough Technologies list was selected by a committee of experts at the Cleveland Clinic, led by D. Geoffrey Vince, PhD, Executive Director of Innovation and Chair of the Department of Biomedical Engineering.

More

To accelerate the development of global biomedical research and development economy and industrialization highland, Shanghai issued policy measures Source: Shanghai Industrial Policy Service Center

In order to increase the total economic contribution of R&D and innovation in Shanghai, accelerate the development of global R&D economy and industrialization, and further foster new growth drivers, the Municipal Development and Reform Commission, together with the Municipal Economic Informatization Commission, the Municipal Science and Technology Commission, the Municipal Health Commission, the Municipal Drug Regulatory Bureau and other departments studied and drafted, The General Office of the Municipal Government issued Several Policies and Measures for Accelerating the Development of Global economic and Industrial Heights of biomedical research and development in Shanghai.

More

Comparable to the country! Three consumables welcome "lowest price in history"

With a wide range of procurement, low price linkage can lead to a hurricane effect, quickly level the remaining price plateau, the national price further level.

More

The Fudan edition of China Hospital Ranking 2021 was released

On Nov. 20, the Fudan edition of "China Hospital Comprehensive Ranking 2021" and the Fudan edition of "China Hospital Specialty Reputation Ranking 2021" were released in Shanghai. The Peking Union Medical College Hospital of the Chinese Academy of Medical Sciences, West China Hospital of Sichuan University, the General Hospital of the People's Liberation Army, Ruijin Hospital Affiliated to the School of Medicine of Shanghai Jiao Tong University and Zhongshan Hospital Affiliated to Fudan University ranked the top five in China's Comprehensive Hospital Ranking 2021. A total of 100 hospitals in China have been listed in the "Dan version of China Hospital Comprehensive Ranking", and 42 specialties (top 10) have been listed.

More

Analysis of export overseas of domestic listed medical device enterprises in 2022

Overseas market demand for epidemic prevention products continues to rise. Based on the statistics of 42 domestic listed medical device enterprises that have disclosed overseas revenue, the compound growth rate of overseas revenue of medical device from 2019 to 2021 is 25.47%, and the overseas revenue scale of listed medical device enterprises in the first half of 2022 is 44.035 billion yuan. Compared with the first half of 2021, the year-on-year growth was 67.83%.

More